Favipiravir for the treatment of patients with COVID-19: a systematic review and meta-analysis

BACKGROUND: Favipiravir possesses high utility for treating patients with COVID-19. However, research examining the efficacy and safety of favipiravir for patients with COVID-19 is limited. METHODS: We conducted a systematic review of published studies reporting the efficacy of favipiravir against C...

Descripción completa

Detalles Bibliográficos
Autores principales: Manabe, Toshie, Kambayashi, Dan, Akatsu, Hiroyasu, Kudo, Koichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8159019/
https://www.ncbi.nlm.nih.gov/pubmed/34044777
http://dx.doi.org/10.1186/s12879-021-06164-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8159019/
https://www.ncbi.nlm.nih.gov/pubmed/34044777
http://dx.doi.org/10.1186/s12879-021-06164-x

Ejemplares similares